BREYANZI Trademark

Trademark Overview

On Thursday, November 5, 2020, a trademark application was filed for BREYANZI with the United States Patent and Trademark Office. The USPTO has given the BREYANZI trademark a serial number of 90300931. The federal status of this trademark filing is REGISTERED as of Tuesday, September 20, 2022. This trademark is owned by JUNO THERAPEUTICS, INC.. The BREYANZI trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical treatment of cancer, lymphoma; provision of information and data for diagnosis and medical treatment
breyanzi

General Information

Serial Number90300931
Word MarkBREYANZI
Filing DateThursday, November 5, 2020
Status700 - REGISTERED
Status DateTuesday, September 20, 2022
Registration Number6853221
Registration DateTuesday, September 20, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 23, 2021

Trademark Statements

Goods and ServicesMedical treatment of cancer, lymphoma; provision of information and data for diagnosis and medical treatment

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, January 5, 2021
Primary Code044
First Use Anywhere DateFriday, February 5, 2021
First Use In Commerce DateFriday, February 5, 2021

Trademark Owner History

Party NameJUNO THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98109
Party NameJUNO THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98109
Party NameJUNO THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSEATTLE, WA 98109

Trademark Events

Event DateEvent Description
Tuesday, September 20, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 20, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, August 17, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, August 16, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, July 30, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 12, 2022USE AMENDMENT FILED
Thursday, July 28, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 12, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, January 18, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2021PUBLISHED FOR OPPOSITION
Wednesday, November 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 20, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 19, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 19, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 19, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 19, 2021NON-FINAL ACTION E-MAILED
Monday, April 19, 2021NON-FINAL ACTION WRITTEN
Monday, April 12, 2021ASSIGNED TO EXAMINER
Tuesday, January 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 9, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

breyanzi medical treatment data diagnosis information lymphoma cancer provision